These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3720592)

  • 1. [Laboratory monitoring of anticoagulant and thrombolysis treatment].
    Vilpo J
    Duodecim; 1986; 102(9):551-9. PubMed ID: 3720592
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laboratory monitoring of antithrombotic treatment].
    Pecka M
    Vnitr Lek; 2006 Mar; 52 Suppl 1():26-30. PubMed ID: 16637446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin therapy: current regimens and principles of monitoring.
    Berry BR; Nantel S
    Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Change in the blood coagulating and fibrinolytic systems in diabetic retinopathy and its treatment with anticoagulant and fibrinolytic preparations].
    Mikhaĭlova NA; Tartakovskaia AI
    Vestn Oftalmol; 1972; 5():88-91. PubMed ID: 4667907
    [No Abstract]   [Full Text] [Related]  

  • 5. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with hemocoagulative and fibrinolytic equilibrium in coronary disease].
    Facchini G; Posteli T; Cremonini G; Bortolotti G; Addarii F
    Atti Soc Ital Cardiol; 1968; 2():122-3. PubMed ID: 5717486
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic preparations and anticoagulants in the treatment of patients with thrombotic stroke].
    Koniukhov SG; Liberzon SP
    Vrach Delo; 1974 Aug; 0(8):21-3. PubMed ID: 4411277
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulants].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1968 Jul; 23(4):217-28. PubMed ID: 4175980
    [No Abstract]   [Full Text] [Related]  

  • 9. [Laboratory diagnostics of susceptibility to venous thrombosis].
    Syrjälä M; Rasi V
    Duodecim; 2001; 117(24):2600-1. PubMed ID: 12183821
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of hemostatic system inhibitors in malignancy.
    Wojtukiewicz MZ; Sierko E; Kisiel W
    Semin Thromb Hemost; 2007 Oct; 33(7):621-42. PubMed ID: 18000789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of a paroxysmal nocturnal hemoglobinuria with increased coagulation activation markers while on treatment with LMWH with anti-Xa levels above the therapeutic range.
    Arkel YS; Ku DH; Lake C; Lam X; Spielvogel A
    Thromb Haemost; 2000 Feb; 83(2):348-9. PubMed ID: 10739398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prescription and monitoring of anticoagulant therapies].
    Laviolle B; Oger E
    Rev Prat; 2008 Nov; 58(18):2063-70. PubMed ID: 19143281
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the sympathetic system in the local release of substances active on coagulation and fibrinolysis.
    Neri Serneri GG; Procacci P; Paoletti P
    Rass Neurol Veg; 1968; 22(4):379-88. PubMed ID: 5714083
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparin in the treatment of unstable angina. Can the decrease of the molecular size increase its effectiveness?].
    Panchenko EP
    Ter Arkh; 1998; 70(12):71-4. PubMed ID: 10067259
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
    Raskob GE
    Curr Opin Pulm Med; 1995 Jul; 1(4):291-7. PubMed ID: 9363067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of blood coagulation disorders on hepatic vascular diseases and therapeutic possibilities].
    García-Pagán JC
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():49-51. PubMed ID: 15195534
    [No Abstract]   [Full Text] [Related]  

  • 18. Reliability of laboratory tests for the control of oral anticoagulation. A comparative study of homemade human brain thromboplastin, the British comparative thromboplastin, simplastin, simplastin A, and thrombotest.
    Loeliger EA; Boekhout-Mussert JM; van Halem-Visser LP; Habbema JD; de Jonge H
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):483-91. PubMed ID: 4450200
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
    Biemond BJ; Perzborn E; Friederich PW; Levi M; Buetehorn U; Büller HR
    Thromb Haemost; 2007 Mar; 97(3):471-7. PubMed ID: 17334516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and therapeutic problems in thromboembolic complications in the surgical patient].
    Magrini M
    Acta Anaesthesiol; 1968; 19():Suppl 7:173+. PubMed ID: 5757484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.